Cargando…
Arthroplasty for tenosynovial giant cell tumors: 17 patients followed for 0.2 to 15 years
BACKGROUND AND PURPOSE: Tenosynovial giant cell tumors (t-GCTs) can behave aggressively locally and affect joint function and quality of life. The role of arthroplasty in the treatment of t-GCT is uncertain. We report the results of arthroplasty in t-GCT patients. PATIENTS AND METHODS: t-GCT patient...
Autores principales: | Verspoor, Floortje G M, Hannink, Gerjon, Scholte, Anouk, Van Der Geest, Ingrid C M, Schreuder, H W Bart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5016909/ https://www.ncbi.nlm.nih.gov/pubmed/27357329 http://dx.doi.org/10.1080/17453674.2016.1205168 |
Ejemplares similares
-
Cryosurgery as Additional Treatment in Tenosynovial Giant Cell Tumors
por: Verspoor, F. G. M., et al.
Publicado: (2016) -
Limb Amputation after Multiple Treatments of Tenosynovial Giant Cell Tumour: Series of 4 Dutch Cases
por: Mastboom, Monique J. L., et al.
Publicado: (2017) -
Higher incidence rates than previously known in tenosynovial giant cell tumors: A nationwide study in The Netherlands
por: Mastboom, Monique J L, et al.
Publicado: (2017) -
The Importance of Awaiting Biopsy Results in Solitary Pathological Proximal Femoral Fractures: Do We Need to Biopsy Solitary Pathological Fractures?
por: Verspoor, Floortje G. M., et al.
Publicado: (2023) -
Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor
por: Verspoor, F. G. M., et al.
Publicado: (2019)